Cutler Group LP Vera Therapeutics, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 1,335 shares of VERA stock, worth $31,719. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,335Holding current value
$31,719% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
64MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$135 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$113 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$79.3 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$70.3 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$69.3 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $643M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...